Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand,Richard A. Furie,Yoshiya Tanaka,Ian N. Bruce,Anca Askanase,Christophe Richez,Sang-Cheol Bae,Philip Z. Brohawn,Lilia Pineda,Anna Berglind,Raj Tummala

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

2020

Eric F. Morand
Richard A. Furie
Yoshiya Tanaka
Ian N. Bruce
Anca Askanase
Christophe Richez
Sang-Cheol Bae
Philip Z. Brohawn
Lilia Pineda
Anna Berglind
Raj Tummala

Abstract Background Anifrolumab, a human monoclonal antibody to type I interferon receptor subunit 1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a significant...

Keywords:

Anifrolumab
Surgery
Type I Interferon Receptor
Medicine
Immunology
Lupus erythematosus
Monoclonal antibody
Protein subunit
Diabetes mellitus
systemic lupus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

274

Citations